Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

SHE:300049 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,357	1,349	1,147	1,001	891.56	800.96
Other Revenue	-	-	6.9	7.37	6.93	6.57
Revenue	1,357	1,349	1,154	1,009	898.48	807.53
Revenue Growth (YoY)	9.89%	16.93%	14.37%	12.27%	11.26%	-2.91%
Cost of Revenue	350.28	349.04	291.39	267.67	239.14	226.65
Gross Profit	1,006	999.98	862.34	741.09	659.34	580.88
Selling, General & Admin	607.07	584.24	527.56	474.49	405.7	361.47
Research & Development	96.23	99.49	82.47	70.82	64.79	65.82
Other Operating Expenses	7.3	7.4	10.43	10.79	12.5	11.39
Operating Expenses	710.6	691.12	617.39	562.68	491.94	440.51
Operating Income	295.73	308.85	244.95	178.41	167.4	140.38
Interest Expense	-	-	-0.9	-1.58	-2.33	-3.21
Interest & Investment Income	0.94	-	12.39	9.73	10.54	3.41
Currency Exchange Gain (Loss)	-	-	-2.32	7.93	16.48	-12.48
Other Non Operating Income (Expenses)	-16.99	-5.48	-0.53	-1.28	-0.26	-0.25
EBT Excluding Unusual Items	279.68	303.37	253.59	193.21	191.83	127.84
Gain (Loss) on Sale of Investments	-22.42	-23.11	-	-	-	-1.6
Gain (Loss) on Sale of Assets	-0.39	-0.31	-0.82	-1.86	-3.46	-6.93
Asset Writedown	-9.4	-9.4	-4.71	-0	-	-
Other Unusual Items	-	-	-12.66	0.29	0.77	-5.32
Pretax Income	247.47	270.55	235.4	191.63	189.14	113.99
Income Tax Expense	75.31	74.67	58.29	46.22	41.1	23.72
Earnings From Continuing Operations	172.16	195.88	177.11	145.41	148.04	90.27
Minority Interest in Earnings	-72.96	-82.59	-75.55	-47.52	-52.57	-28.36
Net Income	99.2	113.29	101.56	97.89	95.47	61.91
Net Income to Common	99.2	113.29	101.56	97.89	95.47	61.91
Net Income Growth	-24.44%	11.54%	3.75%	2.54%	54.22%	42.69%
Shares Outstanding (Basic)	265	264	263	263	260	256
Shares Outstanding (Diluted)	265	264	263	263	260	256
Shares Change (YoY)	0.83%	0.50%	-0.01%	1.30%	1.31%	0.03%
EPS (Basic)	0.37	0.43	0.39	0.37	0.37	0.24
EPS (Diluted)	0.37	0.43	0.39	0.37	0.37	0.24
EPS Growth	-25.06%	10.98%	3.76%	1.22%	52.22%	42.65%
Free Cash Flow	21.88	2.44	115.66	98.69	142.94	90.41
Free Cash Flow Per Share	0.08	0.01	0.44	0.38	0.55	0.35
Dividend Per Share	-	-	-	0.200	-	-
Gross Margin	74.18%	74.13%	74.74%	73.47%	73.38%	71.93%
Operating Margin	21.80%	22.89%	21.23%	17.69%	18.63%	17.38%
Profit Margin	7.31%	8.40%	8.80%	9.70%	10.63%	7.67%
Free Cash Flow Margin	1.61%	0.18%	10.03%	9.78%	15.91%	11.20%
EBITDA	369.17	381.04	312.12	236.39	221.12	209.72
EBITDA Margin	27.21%	28.25%	27.05%	23.43%	24.61%	25.97%
D&A For EBITDA	73.44	72.19	67.18	57.98	53.71	69.35
EBIT	295.73	308.85	244.95	178.41	167.4	140.38
EBIT Margin	21.80%	22.89%	21.23%	17.69%	18.63%	17.38%
Effective Tax Rate	30.43%	27.60%	24.76%	24.12%	21.73%	20.81%
Revenue as Reported	-	-	1,154	1,009	898.48	807.53
Advertising Expenses	-	-	4.76	9.83	9.3	5.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.